Reply to: Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status

Nature Medicine

Volumn 22, Issue 6, 2016, Pages 578-579

  LaFave, Lindsay M ^a   Béguelin, Wendy ^b   Koche, Richard ^a   Teater, Matt ^b   Spitzer, Barbara ^a   Chramiec, Alan ^a   Papalexi, Efthymia ^a   Keller, Matthew D ^a   Hricik, Todd ^a   Konstantinoff, Katerina ^a   Micol, Jean Baptiste ^a   Durham, Benjamin ^a   Knutson, Sarah K ^c   Campbell, John E ^c   Blum, Gil ^a   Shi, Xinxu ^a   Doud, Emma H ^d   Krivtsov, Andrei V ^a   Chung, Young Rock ^a   Khodos, Inna ^a   De Stanchina, Elisa ^a   Ouerfelli, Ouathek ^a   Adusumilli, Prasad S ^a   Thomas, Paul M ^d   Kelleher, Neil L ^d   Luo, Minkui ^a   Keilhack, Heike ^c   Abdel Wahab, Omar ^a   Melnick, Ari ^b   Armstrong, Scott A ^a   Levine, Ross L ^a   more..

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c EPIZYME INC   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYCOMB REPRESSIVE COMPLEX 2; TRANSCRIPTION FACTOR EZH2; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN THIOLESTERASE;

CELL PROLIFERATION; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; HEMATOPOIETIC CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LETTER; MELANOMA CELL LINE; PRIORITY JOURNAL; RNA SEQUENCE; TISSUE SPECIFICITY; TUMOR GROWTH; UVEA MELANOMA; MELANOMA; UVEA TUMOR;

HUMANS; MELANOMA; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN THIOLESTERASE; UVEAL NEOPLASMS;

EID: 84976415504     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.4094     Document Type: Letter

References (8)

1. LaFave, L.M. et al. Nat. Med. 21, 1344-1349 (2015).
2. Schoumacher, M. et al. Nat. Med. 22, 577-578 (2016).
3. Kim, K.H. & Roberts, C.W. Nat. Med. 22, 128-134 (2016).
4. Fong, C.Y. et al. Nature 525, 538-542 (2015).
5. Matatall, K.A. et al. BMC Cancer 13, 371 (2013).
6. Harbour, J.W. et al. Science 330, 1410-1413 (2010).
7. Campbell, J.E. et al. ACS Med. Chem. Lett. 6, 491-495 (2015).
8. Kim, K.H. et al. Nat. Med. 21, 1491-1496 (2015).